Nalmefene for alcohol dependence: Added benefit not proven

No added benefit can be derived from the indirect comparison presented in the drug manufacturer dossier, in particular because the studies on the appropriate comparator therapy were unsuitable. —> Read More Here

facebooktwittergoogle_plusredditpinterestlinkedinmail

Leave a Reply

Your email address will not be published. Required fields are marked *